We are monitoring the impact of COVID-19 on North America Bovine Respiratory Disease Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 848
Share on
Share on

North America Bovine Respiratory Disease Treatment Market Research Report - By Type of Treatment and Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 848
Pages: 145

North America Bovine Respiratory Disease Treatment Market Size (2021 to 2026)

The North America Bovine Respiratory Disease Treatment Market was estimated at USD 16.94 million in 2021. It is further projected to reach USD 39.25 million by 2026, growing at a CAGR of 18.3% during the forecast period. The U.S. feedlot industry estimates a huge annual loss for bovine respiratory disease (BRD) due to loss of production, increased labor expenses, pharmaceutical costs, and death deriving from BRD. 

BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. Bovine Respiratory Disease is far too common, far too costly, and, for the most part, seems far too hard to handle. If cattle are treated more than once, they never get back to that peak performance.

The disease is caused by various factors such as Host factors, which include animal age, immunity, genetics, and exposure to pathogens; environmental factors involve crowding, temperature, commingling and transport, Internal or external parasite infections, and Infectious agents. The weight loss that animal has due to BRD sickness will stay with them throughout the feeding period. Hence, productivity is reduced. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and are expected to improve the treatment's success rate.

This research report segmented and sub-segmented the North America Bovine Respiratory Disease Treatment Market into the following categories:

By Treatment Type: 

  • Anti-Infectious Agents
    • Antibiotics           
    • Sulfas    
  • Anti-Parasiticides                 
  • Bronchodilators                    
  • Oral Rehydration Fluids                     
  • Non-Steroidal Anti-Inflammatories               
  • Mucolytics

By Country: 

  • The United States
  • Canada
  • Rest of North America

Some of the promising companies operating in the North American Bovine Respiratory Disease Treatment Market are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co, Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A., Ceva Sante Animale, and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       



                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 United States                            

                                6.3 Canada                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 


                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Bovine Respiratory Disease Treatment Market, By Region, From 2021 to 2026 (USD Million)
  2. North America Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2021 to 2026 (USD Million)
  3. North America Anti-Infectious Agents Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2021 to 2026 (USD Million)
  5. North America Antibiotics Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Sulfas Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Anti-Parasiticides Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Bronchodilators Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Oral Rehydration Fluids Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Non-Steroidal Anti-Inflammatories Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Mucolytic Market, By Region, From 2021 to 2026 (USD Million)
  12. United States Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2021 to 2026 (USD Million)
  13. United States Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2021 to 2026 (USD Million)
  14. Canada Bovine Respiratory Disease Treatment Market, By Type of Treatment, From 2021 to 2026 (USD Million)
  15. Canada Bovine Respiratory Disease Treatment Market, By Anti-Infectious Agents, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample